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Summary: Small study effects occur when smaller studies show different, often larger, treatment effects than large
ones, which may threaten the validity of systematic reviews and meta-analyses. The most well-known reasons for
small study effects include publication bias, outcome reporting bias and clinical heterogeneity. Methods to account
for small study effects in univariate meta-analysis have been extensively studied. However, detecting small study
effects in a multivariate meta-analysis setting remains an untouched research area. One of the complications is that
different types of selection processes can be involved in the reporting of multivariate outcomes. For example, some
studies may be completely unpublished while others may selectively report multiple outcomes. In this paper, we
propose a score test as an overall test of small study effects in multivariate meta-analysis. Two detailed case studies
are given to demonstrate the advantage of the proposed test over various naive applications of univariate tests in
practice. Through simulation studies, the proposed test is found to retain nominal Type I error with considerable
power in moderate sample size settings. Finally, we also evaluate the concordance between the proposed test with the
naive application of univariate tests by evaluating 44 systematic reviews with multiple outcomes from the Cochrane
Database.
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1. Introduction
In the last several decades, systematic reviews and meta-analyses have received increasing
attention in comparative effectiveness research and evidence-based medicine. Meta-analysis
is a statistical procedure that combines the results of multiple scientific studies. In meta-
analysis, small study effects (SSE) is a well-known critical and challenging issue that may
threaten the validity of the results (Song et al., 2000; Sutton et al., 2000). “Small-study
effects” is a generic term for the phenomenon that smaller studies sometimes show different,
often larger, treatment effects than large ones (Sterne and Egger, 2001). One of the most
well-known reason for SSE is publication bias (PB), in which case the chance of a small study
being published does not depend on its quality, but on its effect size, significance or direction.
A possible reason is that authors tend to report significant or positive results or journals
tend to publish studies with significant or positive results. Besides PB, outcome reporting
bias (ORB) and clinical heterogeneity (i.e. variability in the participants, interventions and
outcomes) in small studies are also important sources for SSE.
SSE (including PB) is arguably the greatest threat to the validity of meta-analysis (Schwarzer
et al., 2015). Erroneous conclusions can arise from a meta-analysis if SSE is not properly
accounted for. For example, conclusions from several meta-analyses were later found to be
contradicted by mega-trials (Egger and Smith, 1995). In the last two decades, a great deal of
effort has been devoted to better reporting protocols, risk of bias evaluation, and statistical
methods to detect and correct for SSE based on reported studies (Rothstein et al., 2006;
Bu¨rkner and Doebler, 2014).
Among the many statistical methods on this issue, funnel plots have been commonly used
to study SSE. Because the precision of an estimated treatment effect generally increases as
the sample size of component studies increases, results from small studies typically scatter
widely at the bottom of the funnel plot, while those from larger studies scatter narrowly
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at the top. An asymmetric inverted funnel is often equated with potential PB (Light and
Pillemer, 1984; Sterne and Egger, 2001). It is worth mentioning that although a funnel plot is
commonly used to detect PB, it should be seen as a generic means of displaying different types
of small-study effects, not limited to PB only (Egger et al., 1997; Sterne and Egger, 2001).
However, observations based on funnel plots can themselves be subjective as demonstrated
by (Lau et al., 2006). Without quantitatively measuring the funnel plot symmetry, different
observers may reach different conclusions. Statistical tests based on funnel plot symmetry
have been developed, including the rank correlation test (Begg and Mazumdar, 1994) and
regression-based tests (Egger et al., 1997; Macaskill et al., 2001; Harbord et al., 2006; Peters
et al., 2006; Ru¨cker et al., 2008). Using the symmetry of funnel plots, Duval and Tweedie
(2000a,b) further developed the nonparametric “Trim and Fill” method for imputing missing
studies in a meta-analysis.
Multivariate meta-analysis (MMA), which jointly analyzes multiple and possibly correlated
outcomes, has recently received a great deal of attention (Jackson et al., 2011a). By borrowing
information across outcomes, MMA improves estimation of both pooled effects and between-
study variances. However, to the best of our knowledge, statistical tests that quantify the
evidence of SSE for multivariate meta-analysis data have not been developed. In fact, there
are several unique challenges in MMA that need to be properly addressed in developing a
sensible test to study SSE in MMA.
The first challenge comes from various scenarios of SSE. Unlike univariate meta-analysis,
some studies may have only part of their outcomes selectively reported, known as outcome
reporting bias (ORB) (Chan and Altman, 2005). ORB has received less attention than PB
despite its high prevalence in the literature (Dwan et al., 2008). More precisely, by comparing
trial publications to protocols, Dwan et al. (2008) found strong evidence that outcomes that
are statistically significant have a higher probability of being reported. More recently, an
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investigation of the impact of ORB in reviews of rheumatoid arthritis from the Cochrane
Database of Systematic Reviews (hereinafter refer to as the “Cochrane Database”) suggests
that ORB has the potential to affect the conclusion in meta-analysis (Frosi et al., 2015).
Therefore, a measure to quantify SSE needs to include both PB and ORB scenarios.
The second challenge is to fully account for the multivariate nature of MMA. With multiple
outcomes, a common practice is to apply a univariate test, such as the Egger’s test, to each
of outcomes and report PB for outcomes with small p-values (Chan et al., 2004; Jun et al.,
2010; Kavalieratos et al., 2016). The problem of multiple testing is often ignored, which may
cause excessive false positive findings. For example, Kavalieratos et al. (2016) investigated
the association of palliative care with quality of life, symptom burden, survival, and other
outcomes for people with life-limiting illness and for their caregivers. In their evaluation of
risk of PB, they applied Egger’s test to each of the three primary outcomes and yielded
p-values of 0.03, 0.09 and 0.37 respectively. And they concluded that quality of life and
symptom burden are subject to PB. A more rigorous approach is to apply a Bonferroni
correction to the multiple tests. However, as multiple outcomes are often correlated, the
tests are correlated and hence the Bonferroni correction is conservative. As lack of power is
a well acknowledged concern in detection of PB (Turner et al., 2013), separately applying
a Bonferroni correction to each outcome can further reduce the statistical power (Rothstein
et al., 2006). Thus, in the effort of studying SSE in MMA, we shall aim to apply the strength
of MMA by combining information across outcomes.
The third challenge is that within-study outcome correlations, typically required by MMA
methods, are often not reported and are difficult to obtain even on request (Riley et al.,
2008; Chen et al., 2015). As a consequence, the standard likelihood involves unknown within-
study correlations, which makes the traditional likelihood based tests (e.g., Wald, score and
likelihood ratio tests) not applicable.
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In this paper, we propose a score test to study the overall evidence of SSE. To the best
of our knowledge, this is the first test for SSE in MMA setting. The proposed test has
the following properties. First, by combining evidence of SSE across multiple outcomes,
the proposed test can detect SSE due to PB and/or ORB. Secondly, by jointly modeling
multivariate outcomes, the proposed test fully accounts for the multivariate nature of MMA,
which avoids the separate investigations of individual outcomes. We demonstrate the superior
power of the proposed test as compared to the simple procedure of separate investigation
of outcomes. Furthermore, the proposed test is based on a pseudolikelihood of MMA in the
same spirit as Chen et al. (2014). A key advantage is that within-study correlations are
not required. Lastly, the test statistic has a closed-form formula and a simple approximated
distribution.
The remainder of this paper is organized as follows. In Section 2, we propose the pseudo-
likelihood and the corresponding score test. In Section 3, we illustrate the proposed test using
two case studies. In Section 4, we conduct simulation studies to compare the proposed test
with univariate tests, and investigate the practical implications of the proposed test through
an empirical evaluation of 44 systematic reviews from the Cochrane Database. Finally, we
provide a brief discussion in Section 5.
2. Method
In this section, we introduce notation for the multivariate random-effects meta-analysis and
review the existing funnel-plot-based methods for detecting SSE, including Egger’s regression
test and two of its variations, Begg’s rank test and the Trim and Fill method.
2.1 Notations for multivariate random-effects meta-analysis
We consider a meta-analysis with m studies where a common set of J outcomes are of
interest. For the ith study, let Yij and sij denote, respectively, the summary measure for
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the jth outcome and the associated standard error, both assumed known, for i = 1, . . . ,m
and j = 1, . . . , J . Each summary measure Yij is an estimate of the true effect size θij. To
account for heterogeneity in effect size across studies, we assume θij to be independently
drawn from a common distribution with overall effect size βj and between-study variance τ
2
j ,
j = 1, . . . , J . Under the assumption of a normal distribution for Yij and θij, a multivariate
random-effects model is often taken to be

Yi1
...
YiJ
 ∼ N


θi1
...
θiJ
 ,∆i
 , ∆i =

s2i1 . . . si1siJρWi(1J)
...
. . .
...
siJsi1ρWi(1J) . . . s
2
iJ
 , (1)

θi1
...
θiJ
 ∼ N


β1
...
βJ
 ,Ω
 , Ω =

τ 21 . . . τ1τJρB(1J)
...
. . .
...
τJτ1ρB(1J) . . . τ
2
J
 , (2)
where ∆i and Ω are J × J study-specific within-study and between-study covariance matri-
ces, respectively, and ρWi(jk) and ρB(jk) are the respective within-study and between-study
correlations between the jth and kth outcomes (Jackson et al., 2011a). When the within-
study correlations ρWi(jk) are known, inference on the overall effect sizes (β1, . . . , βJ) can be
based on the marginal distribution of (Yi1, . . . , YiJ), i.e.,

Yi1
...
YiJ
 ∼ N


β1
...
βJ
 ,Vi
 , Vi = ∆i + Ω. (3)
We note that the variance of Yij is partitioned into two parts (s
2
ij and τ
2
j ) as in analysis of vari-
ance (ANOVA) for univariate random-effects models, and the covariance is also partitioned
into two parts as the sum of within- and between-study covariances, i.e., cov(Yij, Yik) =
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sijsikρWi(jk) + τjτkρB(jk). However, study-specific within-study correlations ρWi(jk) among
multiple outcomes are generally unknown (Riley et al., 2008; Chen et al., 2014).
2.2 A score test for multivariate meta-analysis
Due to the recent development of MMA on multiple outcomes and multiple treatments (e.g.,
network meta-analysis), the statistical tests based on funnel plot symmetry for univariate
outcomes are no longer applicable. In this section, we propose a score test for SSE under
MMA. The proposed test can be considered as a multivariate extension of Egger’s regression
test, which allows for different types of SSE, fully accounts for the multivariate nature of
MMA, and does not require within-study correlations.
A standard score test based on the likelihood function of the model (3) can account for the
multivariate nature, as well as borrow information across outcomes. However, the within-
study correlations, which are often not reported in the literature, are required in order to
calculate the test statistic and to allow for borrowing information across outcomes. Our
strategy is to first construct a pseudolikelihood without the use of within-study correlations
and then use the corresponding score test for SSE.
We refer to our test as the Multivariate Small Study Effect Test (MSSET) hereinafter.
Specifically, we calculate each component of the pseudolikelihood (Gong and Samaniego,
1981) using the estimated residuals in the regression model of the univariate Egger’s test
and then employ the idea of composite likelihood (Lindsay, 1988) to combine individual
pseudolikelihoods together. For the jth outcome of the ith study, define the standardized
effect size as SNDij = Yij
(
s2ij + τ
2
j
)−1/2
and the precision as Pij =
(
s2ij + τ
2
j
)−1/2
. We have
SNDij = aj + βjPij + εij, (4)
where εij is a standard normal random variable. Let τ˜
2
j denote a consistent estimator
of τ 2j (e.g., a moment estimator). By substituting τ˜
2
j into model (4), we obtain the log
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pseudolikelihood
logLjp(aj, bj) = −
1
2
m∑
i=1
(S˜NDij − aj − bjP˜ij)2, (5)
where S˜NDij and P˜ij are simply SNDij and Pij with τ
2
j replaced by τ˜
2
j . We note here
that the regression coefficients (aj, bj) (in particular aj) are parameters of interest, while
the heterogeneity τ 2j is a nuisance parameter. Replacing the nuisance parameter by its
estimate can reduce its impact and offer a simple inference procedure. Such an idea was
originally proposed by Gong and Samaniego (1981), where the uncertainty associated with
the estimated nuisance parameters is properly accounted for, and it was later studied by
Liang and Self (1996) and Chen and Liang (2010) in various settings.
To combine the signal for SSE from multivariate outcomes, we propose the following
pseudolikelihood by synthesizing individual pseudolikelihoods across outcomes:
logLp(a,b) =
J∑
j=1
logLjp(aj, bj), (6)
where a = (a1, . . . , aJ)
T and b = (b1, . . . , bJ)
T . By simply adding together the log pseudo-
likelihoods for the various outcomes, we avoid the use of within-study correlations. This idea
is similar to the composite likelihood (Lindsay, 1988) or independence likelihood (Chandler
and Bate, 2007), where (weighted) likelihoods are multiplied together whether or not they
are independent. An important distinction here is that each component in logLp(a,b) is a
pseudolikelihood (instead of a likelihood), and its score function is not an unbiased estimating
equation. Using a similar argument as in the proofs of Lemma 2.1 and Theorem 2.2 in Gong
and Samaniego (1981), for the jth outcome, we have shown the asymptotic consistency
and normality of the maximum pseudolikelihood estimator in Appendices A and B of the
Supplementary Materials.
With the pseudolikelihood in equation (6), testing SSE in MMA can be carried out by
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simply testing H0 : a = 0, where a = (a1, . . . , aJ)
T . We propose the following procedure,
where the calculation at each step has a closed-form expression.
(1) Calculation of the pseudo-score function
The maximum pseudolikelihood estimator under aj = 0 can be calculated as
b˜j(0) =
(
m∑
i=1
P˜
2
ij
)−1( m∑
i=1
S˜NDijP˜ij
)
.
The pseudo-score function w.r.t. a under the null can be calculated as Ua
[
0, b˜(0), τ˜2
]
=(∑m
i=1 S˜NDi1 − R1, . . . ,
∑m
i=1 S˜NDiJ − RJ
)T
, where Rj = b˜j(0)
∑m
i=1 P˜ij. For notation
simplicity, we use Ua
[
0, b˜(0)
]
to denote Ua
[
0, b˜(0), τ˜2
]
hereafter.
(2) Calculation of information matrices
The negative Hessian of the log pseudolikelihood function evaluated at (0, b˜(0)) is
calculated as
I0 =
 I0aa I0ab
I0ab
T I0bb
 ,
where I0aa = diag(m, . . . ,m) is a J-dimensional diagonal matrix with m as its diagonal
elements, I0ab = diag(
∑m
i=1 Pi1, . . . ,
∑m
i=1 PiJ) is a J-dimensional diagonal matrix with∑m
i=1 Pij as its jth element, and I0bb = (
∑m
i=1 P
2
i1, . . . ,
∑m
i=1 P
2
iJ) is a J-dimensional
diagonal matrix with
∑m
i=1 P
2
ij as its jth element. The J × J submatrix of the inverse of
I0 with respect to a, denoted by I
aa
0 , can be calculated as
(
I0aa − I0aaI−10bbI0ab
)−1
.
(3) Calculation of the test statistic
Let Σaa denote the asymptotic variance of
√
m(aˆ− a0). The calculation of Σaa requires
properly accounting for the additional uncertainty in τ˜ 2, as we described in Appendix C
of the Supplementary Materials. Let λ¯ denote the arithmetic mean of the eigenvalues of
(Iaa0 )
−1Σaa. The proposed MSSET test is constructed by
MSSET =
(
mλ¯
)−1
Ua
[
0, b˜(0)
]T
I0
aaUa
[
0, b˜(0)
]
. (7)
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The test statistic is compared with the χ2J distribution to obtain a p-value.
A proof of the asymptotic distribution of the score test is provided in Appendix C of
the Supplementary Materials. We note that instead of constructing the test following the
traditional score test for composite likelihood (e.g., the pseudo-score statistics defined on
page 193 in Molenberghs and Verbeke (2005)), the above test is constructed for better
computational stability. Finally, the proposed test reduces to the traditional Egger’s test
for univariate meta-analysis when the number of outcomes is one (i.e., J = 1). The above
steps for obtaining the MSSET and p-value will be illustrated in Section 4.1.
2.3 A modified version of MSSET for multivariate meta-analysis with binary outcomes.
The proposed MSSET test, along with the Egger’s regression, assume that, under the null
hypothesis of no SSE, there is no association between effect size and precision. However, this
does not hold for binary outcomes. For example, if a binary outcome is summarized by the
log-odds ratio (logOR), the variance estimators of logOR are statistically dependent of the
estimated logOR. This may induce inflated type I errors. To reduce the correlation between
the effect size and precision, Peters test, Harbords score test, and Ruckers Arcsine-Thompson
(AS-Thompson) test have been proposed for randomized clinical trials with balanced sample
sizes. Jin et al. (2014) proposed a regression method using a smoothed variance as the
precision scale of an individual study to test for publication bias, and suggested that the
smoothed regression method is more robust across different settings. In the same spirit as in
Jin et al. (2014), we modified the MSSET test by replacing the within-study variance sij in
equation (3) by its smoothed version.
For illustration, consider a bivariate meta-analysis of n individual studies, where the jth
outcome is binary summarizing in logOR. For the ith study, let ai and bi denote numbers
of cases and controls in the exposed group, and ci and di denote numbers of cases and
controls in the unexposed group. We obtain the logOR and its variance as log(aidi/bici), and
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1/ai + 1/bi + 1/ci + 1/di, which are intrinsically correlated. To reduce the correlation, the
estimated smoothed variance for the estimated logOR is given by
{(ai + ci)p1/n}−1+{(ai + ci)(1− p1)/n}−1+{(bi + c = di)p0/n}−1+{(bi + di)(1− p0)/n}−1 ,
where p1 =
∑n
i=1 {ai/(ai + ci)}, and p0 =
∑n
i=1 {bi/(bi + di)}.
3. Two case studies
In this section, we consider two case studies: 1) structured telephone support or non-invasive
tele-monitoring for patients with heart failure and 2) prognostic value of MYCN and Chro-
mosome 1p in patients with neuroblastoma.
3.1 Structured telephone support or non-invasive tele-monitoring for patients with heart
failure
Heart failure is a complex, debilitating disease. To improve clinical outcomes, and reduce
healthcare utilization, specialized disease management programs are conducted, such as
structured telephone support and non-invasive home telemonitoring. Over the last decade,
trials have been conducted to examine the effects of these programs. To compare structured
telephone support or non-invasive home tele-monitoring interventions with standard practice,
Inglis et al. (2016) conducted a systematic review including 41 randomized clinical trials.
Primary outcomes included all-cause mortality, and both all-cause and heart failure-related
hospitalizations. Other outcomes included length of stay, health-related quality of life, heart
failure knowledge and self-care, acceptability and cost.
We revisit the systematic review conducted by Inglis et al. (2016), and use the primary
outcome (all-cause mortality) and the secondary outcome (mental quality of life) to illustrate
the proposed method. We analyze the 35 trials that reported either of the two outcomes.
Among the 35 trials, 11 reported both outcomes; 34 reported the primary; and 12 reported
the secondary outcome.
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[Figure 1 about here.]
We now illustrate the steps in the proposed MSSET. First we obtain b(0) = (−0.20, 0.13)T .
The pseudo-score function under the null hypothesis is Ua
[
0, b˜(0)
]
= (−4.84, 1.32)T . We
then calculate the negative Hessian of the log pseudolikelihood,
I0 =

41.00 91.46 0.00 0.00
91.46 324.40 0.00 0.00
0.00 0.00 41.00 57.54
0.00 0.00 57.54 292.79

.
The 2× 2 submatrix of the inverse of I0 w.r.t. a is calculated as
Iaa0 =
 6.57E− 02 0
0 3.37E− 02
 .
We then get
Σaa0 =
 7.10E− 04 −2.79E− 07
−2.79E− 07 1.10E− 05
 ,
and λ¯ = 0.05. The proposed test statistic MSSET can be obtained from equation (7) as 7.02.
By comparing with χ22, the p-value is found to be 0.03.
The upper panel in Figure 1 displays the funnel plots of all-cause mortality and mental
quality of life of 35 trials. The funnel plots of both all-cause mortality and quality of life
suggest severe asymmetry. Such an observation is confirmed by univariate tests of SSE
(Egger’s test), as we summarize in the upper panel in Table 1. When we apply Eggers
test to the two outcomes separately, both are marginally significant (p=0.09 and 0.06).
But after Bonferroni correction, both are not significant. In contrast, the proposed test
yields statistically significant result with smaller p-values. We use this example to highlight
a limitation of univariate tests: the loss of power after adjusting for multiple testing. In
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contrast, the proposed MSSET test is better in identifying SSE by combining signals of SSE
from multiple outcomes.
[Table 1 about here.]
3.2 MCYN and Chromosone 1p in patients with neuroblastoma
Neuroblastoma, a type of cancer that starts in early nerve cells, is a common extracranial
solid tumor of childhood (Huang and Weiss, 2013). One of the best-characterized genetic
marker of risk in neuroblastoma is amplification of MYCN, which is usually used as a
prognostic indicator. Studies have been conducted to assess whether amplified levels of
MYCN and deletion of chromosome 1p, Ch1p, are associated with survival outcomes in
children with neuroblastoma. Jackson et al. (2011b) conducted a meta-analysis to examine
the association of the two factors (MYCN and Chromosome 1p) with overall and disease-free
survival. Seventy-three studies assessing the prognostic values of MYCN and Chromosome
1p, in patients with neuroblastoma are included in this meta-analysis. Up to four estimates
of effect are provided by the individual studies, including an estimated unadjusted log hazard
ratio of survival, either of the high relative to the low level group of MYCN, or Chromosome
1p deletion to its presence.
We study the SSE for overall survival and disease free survival using Egger’s test and
the proposed MSSET test. The lower panel in Figure 1 displays the funnel plots of the
two outcomes. For the overall survival, we observe a certain degree of asymmetry, while for
the disease-free survival, we do not observe such evidence. Similarly, as shown in the lower
panel in Table 1, applying univariate methods for SSE to outcomes separately only lead to
the detection of SSE for overall survival. The proposed MSSET test suggests a statistically
significant evidence of overall SSE for bivariate outcomes.
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4. Simulation studies and an empirical evaluation using 44 systematic reviews
In this section, we evaluate the performance of the proposed MSSET test through fully
controlled simulation studies, and study the empirical impact of our new MSSET.
4.1 Simulation studies
In our simulation studies, we compare the proposed MSSET test with the commonly used
Egger’s regression test and Begg’s rank test. The data are generated from MMA with a
common set of two outcomes as specified by model (1). To cover a wide spectrum of scenarios,
we vary the values of several factors that are considered important in practice: 1) To reflect
the heterogeneity in the standard error of the summary measure across studies, we sample
s2ij from the square of the distribution N(0.3, 0.5), which leads to a mean value of 0.33 for s
2
ij.
2) The size of the within-study variation relative to the between-study variation may have
a substantial impact on the performance of the methods. To this end, we let the between-
study variances τ 21 = τ
2
2 range from 0.1 to 2 to represent the random-effects model with
relatively small to large random effects. 3) For within-study and between-study correlations,
we consider ρWi to be constant with value −0.5, 0, or 0.5 and ρB to be constant with value
−0.5, 0, or 0.5. 4) The number of studies n is set to 10, 25, 50, or 100 to represent meta-
analysis of small to large numbers of studies. We consider the Type I error setting where the
selection (i.e., the decision of whether to publish a particular study or report a particular
outcome) does not depend on the effect sizes. We also consider the power settings where
the selection depends on the effect sizes. We conduct 5000 simulations for the Type I error
setting and 1000 simulations for the power settings. For the power settings, in order to obtain
n published studies, we follow three steps: 1) N studies are simulated, where N is an integer
greater than n (here we choose N = 3n to ensure there are enough studies before selection);
2) studies are excluded based on four different selection scenarios described in the following
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paragraph; and 3) n studies are sampled randomly from those that remain after the previous
step.
4.1.1 Selection model scenarios. To evaluate the usefulness and performance of the pro-
posed MSSET test in detecting the SSE in multivariate meta-analysis setting, it is critical
to design and cover a wide range of publication/reporting scenarios, which we refer to as
selection model scenarios. We consider four different scenarios for two types of SSE, including
scenarios where studies are completely missing (denoted by Scenario C1, C2, and C3), and
scenarios where studies are partially missing (denoted by Scenario P).
For Scenarios C1–C3, the probability of a study being published depends on the p-values
of both effect sizes of this study. For example, as shown in the upper left panel of Figure 2, a
study is published if and only if the p-values of both effect sizes are less than 0.05. Although
Scenarios C2 and C3 may be more common in practice, we include Scenario C1 as it was
usually considered in the literature as a benchmark for sanity check of a procedure (Bu¨rkner
and Doebler, 2014). The scenarios C2 and C3 in the upper right and lower left of Figure 2,
can be thought as a “smoothed” version of scenario C1 where the publication of a study
relies on, but is not totally decided by the significance of two outcomes.
For Scenario P (P stands for partial reporting), as visualized in the lower-right panel of
Figure 2, the probability of an outcome being reported depends on the p-value of its effect
size; therefore, some studies may selectively report only one of the outcomes. In addition,
the selection model in Scenario P is different from those in Scenarios C1–C3 in that we let
the logit of the probability of the jth outcome in the ith study being published be (−2.5 +
0.1SNDij + 1.5SND
2
ij)I(SNDij < 2) + 4I(SNDij > 2). This selection model is empirically
estimated from a meta-analysis where the true status of a registered study being published
or not is available (Turner et al., 2008), making this scenario most practically plausible.
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A brief description, as well as the data of obtaining this selection model are provided in
Appendix D of the Supplementary Materials.
[Figure 2 about here.]
4.1.2 Simulation results. Table 2 summarizes the Type I errors at the 10% nominal level
of the tests under comparison. The proposed MSSET test controls the Type I errors well
in all settings. The Egger’s regression test for one outcome only (Egger1) or two outcomes
separately with Bonferroni correction (Egger) have slightly inflated Type I errors when the
sample size is small (n = 10). We observe that the Type I errors of Begg’s rank test are very
conservative when the sample size is relatively small but inflated when it is relatively large.
This observation is consistent with the literature, where investigators report that Begg’s rank
test does not perform well in controlling Type I errors (Bu¨rkner and Doebler, 2014).
[Table 2 about here.]
[Figure 3 about here.]
Figure 3 summarizes the power of the tests under comparison. Clearly, the proposed MS-
SET test is the most powerful under all the settings considered. Egger’s regression test on
one outcome (Egger1) and that on two outcomes with Bonferroni correction (Egger) have
substantial power loss compared with the proposed MSSET. There are several additional
interesting findings from Figure 3:
1) For Scenarios C1–C3, we observe non-monotonic trends for the MSSET test and Egger’s
regression test. A possible explanation for this non-monotonicity is due to the fact that both
the MSSET test and Egger’s regression test assume the random-effects model and require
the estimation of the between-study variance τ 2. However, when the between-study variance
is close to zero, a fixed-effect model is more suitable than a random-effects model. Therefore,
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these two tests have lower power as heterogeneity is very small, as a consequence of lack of
good fit assumed for the random-effect meta-analysis model.
2) Unlike in Scenarios C1–C3, the power curve in Scenario P is increasing. One possible
explanation is that this scenario allows selective reporting of parts of multiple outcomes.
Because the proposed test combines signals of SSE across multiple outcomes, the number of
studies required to identify the same degree of heterogeneity is smaller than that required
for the other scenarios.
3) We observe that there is a decreasing trend in power from Scenario C1 to Scenario C3
for all tests under comparison. This indicates that it is easier to detect SSE when selectivity
is greater.
4.1.3 Additional results for multivariate meta-analysis with binary outcomes. To evaluate
the performance of the modified version of MSSET using smoothed within-study variance
for binary outcomes as described in Section 2.3 (referred as MSSETsmooth hereafter), we
consider additional settings where a bivariate meta-analysis has one continuous outcome and
one binary outcome. We compare the MSSETsmooth test with different versions of Egger’s
regression method, including the Egger’s test on the first outcome only using smoothed
variance (denoted as Egger1,smooth), Bonferroni correction of Egger’s test on both outcome
using smoothed variance (denoted as Eggersmooth) , and the Egger’s test using original
variance. We only consider the Type I error setting, because the correlated effect size
and original within-study variance are suggested to lead to inflated Type I errors. Table 3
summarizes the Type I errors at the 10% nominal level of the tests under comparison. In
general, the proposed MSSET test controls the Type I errors better than the various versions
of Egger’s tests under different sample size settings. The Egger’s tests with original variance
produce inflated Type I errors. This observation is consistent with the literature, where the
correlated effect size and its variance will lead to false positive testing results of SSE. The
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Egger’s tests using smoothed variance control the Type errors better than those using naive
variances.
[Table 3 about here.]
4.2 An empirical evaluation using 44 systematic reviews from the Cochrane Database
To evaluate the practical impact of the proposed MSSET, we compare the results of the
proposed multivariate test of SSE with the results from univariate tests of SSE by applying
the proposed MSSET test and the Egger’s test to a large number of comparable meta-analyses
obtained from the Cochrane Database of Systematic Reviews, an online collection of regularly
updated systematic reviews and meta-analyses of medical studies. We do not include the
Begg’s test for comparison, since our simulation study in the previous session indicated that
Begg’s rank test does not perform well in controlling Type I errors. We extracted 5320 out of
11401 available reviews from the database before July 2015 (6081 files were corrupt). Among
these records, we identified 1675 meta-analyses that compare treatment to placebo or no
treatment. The following criteria were then applied: a) the number of studies in a meta-
analysis must be at least 10; b) all studies in a meta-analysis must contain a common set of
two different outcomes; and c) in any meta-analysis, at least one study should report both
outcomes. Similar criteria have been used in the literature (Trikalinos et al., 2014). After
imposing the above quality control, we obtained 44 meta-analyses with bivariate outcomes.
We compare the results from the proposed MSSET test with the results of the univariate
Egger’s test on bivariate outcomes separately. Specifically, for each meta-analysis, we apply
the proposed MSSET test, the Egger’s test on outcome 1 (Egger1), and the Egger’s test
on outcome 2 (Egger2). We then dichotomize the p-value at the level of 0.10, for MSSET
test, Egger1 and Egger2. In addition, we use Bonferroni correction to combine the results
from Egger’s test of bivariate outcomes (EggerBonferroni). We cross-tabulate the dichotomized
results, comparing the MSSET test results with one of the univariate tests. Table 4 shows
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2×2 tables of the number of meta-analyses that identified SSE via the MSSET test, versus
one of the three Egger’s tests.
Among the 44 meta-analyses considered in the analysis, the proposed MSSET test has
identified 7 (16%) meta-analyses with SSE at the significance level of 0.10. Egger’s regression
test has identified 4 (9%) meta-analyses having SSE for both outcome 1 and outcome 2. For
both outcomes with Bonferroni correction, Egger’s regression test and Begg’s rank test has
identified 6 (14%) meta-analyses having SSE. The percentage of SSE identified by the MSSET
test is the highest among all tests, which is consistent with the simulation results showing
that the MSSET test is the most powerful among all tests under comparison. In addition,
the proposed MSSET is in a larger concordance with the EggerBonferroni test, by combining
signals from both outcomes.
In summary, this “meta-meta” analysis of 44 reviews from the Cochrane Database demon-
strates the practical implications of the proposed MSSET by comparing the test to the results
of univariate tests. The MSSET has consistently detected more SSE than the univariate tests.
[Table 4 about here.]
5. Discussion
MMA is becoming more common and has the potential to make an important contribution
to evidence-based medicine (Jackson et al., 2011a). Studying and quantifying the overall
evidence of SSE in MMA is of critical importance for evaluating the validity of systematic
reviews (Rothstein et al., 2006; Bu¨rkner and Doebler, 2014). In this paper, we have proposed
a rigorous score test for studying overall evidence of SSE in MMA. To the best of our
knowledge, the proposed test is the first effort to study SSE in an MMA setting. It can
be thought of a multivariate extension of Egger’s regression test, which naturally is Egger’s
test when the number of outcomes is one (i.e., J = 1). For more general settings (J > 2),
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the proposed test has the following advantageous properties, besides its simplicity. First, by
combining signals of SSE across multiple outcomes (whether or not they are of different data
types or on different scales), the proposed test can quantify SSE under different scenarios,
and is consistently more powerful than univariate tests. Second, by jointly modeling multiple
outcomes, the score test can fully account for the multivariate nature of MMA, which
avoids the need of a Bonferroni correction for multiple testing. As a technique and practical
advantage, the within-study correlations are not required in the proposed test, while the
between-study correlations are properly accounted for in the testing procedure, by the theory
of composite likelihood.
Outcome reporting bias (ORB) had not received sufficient attention until recently (Chan
and Altman, 2005; Dwan et al., 2013). Dwan et al. (2013) reviewed the evidence from
empirical cohort studies assessing ORB and showed that statistically significant outcomes
are more likely to be selectively reported. Copas et al. (2014) suggested a likelihood-based
model that reflects the empirical findings to estimate the severity of ORB. More recently,
Frosi et al. (2015) suggested that the difference between the results from MMA and those
from univariate meta-analysis indicates the presence of ORB. Designing a specific test for
detecting ORB is a topic of future research.
A limitation of the proposed method is that it only detects for SSE and does not correct
for it. An important extension is to develop a robust procedure to correct for SSE by jointly
analyzing multivariate outcomes. Another interesting extension of the proposed test is to
network meta-analysis, where multiple treatments are compared jointly in clinical trials but
each trial may compare only a subset of all treatments.
To summarize, we have developed a simple and useful test to detect SSE in a multivariate
meta-analysis setting. As a natural extension of the univariate Egger’s regression test, our
test has the advantage of combining signals across outcomes without requiring within-study
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correlations. We have found that the proposed test is substantially more powerful than the
univariate tests and has a practical impact on real applications, calling for more attention
on potential SSE or PB during research synthesis. We believe this test is a useful addition
for tackling the problem of SSE and PB in comparative effectiveness research.
References
Begg, C. B. and Mazumdar, M. (1994). Operating characteristics of a rank correlation test
for publication bias. Biometrics pages 1088–1101.
Bu¨rkner, P.-C. and Doebler, P. (2014). Testing for publication bias in diagnostic meta-
analysis: a simulation study. Statistics in Medicine 33, 3061–3077.
Chan, A.-W. and Altman, D. G. (2005). Identifying outcome reporting bias in randomised
trials on pubmed: review of publications and survey of authors. bmj 330, 753.
Chan, A.-W., Hro´bjartsson, A., Haahr, M. T., Gøtzsche, P. C., and Altman, D. G. (2004).
Empirical evidence for selective reporting of outcomes in randomized trials: comparison
of protocols to published articles. Jama 291, 2457–2465.
Chandler, R. and Bate, S. (2007). Inference for clustered data using the independence
loglikelihood. Biometrika 94, 167–183.
Chen, Y., Cai, Y., Hong, C., and Jackson, D. (2015). Inference for correlated effect sizes
using multiple univariate meta-analyses. Statistics in medicine .
Chen, Y., Hong, C., and Riley, R. D. (2014). An alternative pseudolikelihood method for
multivariate random-effects meta-analysis. Statistics in Medicine .
Chen, Y. and Liang, K.-Y. (2010). On the asymptotic behavior of the pseudolikelihood ratio
test statistic with boundary problems. Biometrika 97, 603–620.
Copas, J., Dwan, K., Kirkham, J., and Williamson, P. (2014). A model-based correction for
outcome reporting bias in meta-analysis. Biostatistics 15, 370–383.
Duval, S. and Tweedie, R. (2000a). A nonparametric trim and fill method of accounting for
Testing small study effects in multivariate meta-analysis 21
publication bias in meta-analysis. Journal of the American Statistical Association 95,
89–98.
Duval, S. and Tweedie, R. (2000b). Trim and fill: a simple funnel-plot–based method of
testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455–463.
Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E.,
Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008). Systematic review of the
empirical evidence of study publication bias and outcome reporting bias. PLoS Clinical
Trials 5,.
Dwan, K., Gamble, C., Williamson, P. R., Kirkham, J. J., et al. (2013). Systematic review of
the empirical evidence of study publication bias and outcome reporting biasan updated
review. PloS one 8, e66844.
Egger, M. and Smith, G. D. (1995). Misleading meta-analysis. British Medical Journal 310,
752–754.
Egger, M., Smith, G. D., Schneider, M., and Minder, C. (1997). Bias in meta-analysis
detected by a simple, graphical test. British Medical Journal 315, 629–634.
Frosi, G., Riley, R. D., Williamson, P. R., and Kirkham, J. J. (2015). Multivariate meta-
analysis helps examine the impact of outcome reporting bias in cochrane rheumatoid
arthritis reviews. Journal of clinical epidemiology 68, 542–550.
Gong, G. and Samaniego, F. J. (1981). Pseudo maximum likelihood estimation: Theory and
applications. Annals of Statistics 9, 861–869.
Harbord, R. M., Egger, M., and Sterne, J. A. (2006). A modified test for small-study effects
in meta-analyses of controlled trials with binary endpoints. Statistics in medicine 25,
3443–3457.
Huang, M. and Weiss, W. A. (2013). Neuroblastoma and mycn. Cold Spring Harbor
perspectives in medicine 3, a014415.
22 Biometrics, 0000
Inglis, S. C., Clark, R. A., Dierckx, R., Prieto-Merino, D., and Cleland, J. G. (2016).
Structured telephone support or non-invasive telemonitoring for patients with heart
failure.
Jackson, D., Riley, R., and White, I. (2011a). Multivariate meta-analysis: Potential and
promise. Statistics in Medicine 30, 2481–2498.
Jackson, D., Riley, R., and White, I. R. (2011b). Multivariate meta-analysis: Potential and
promise. Statistics in Medicine 30, 2481–2498.
Jin, Z.-C., Wu, C., Zhou, X.-H., and He, J. (2014). A modified regression method to
test publication bias in meta-analyses with binary outcomes. BMC medical research
methodology 14, 132.
Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A.,
Chalmers, J., and Perkovic, V. (2010). Effects of fibrates on cardiovascular outcomes: a
systematic review and meta-analysis. The Lancet 375, 1875–1884.
Kavalieratos, D., Corbelli, J., Zhang, D., Dionne-Odom, J. N., Ernecoff, N. C., Hanmer,
J., Hoydich, Z. P., Ikejiani, D. Z., Klein-Fedyshin, M., Zimmermann, C., et al. (2016).
Association between palliative care and patient and caregiver outcomes: a systematic
review and meta-analysis. JAMA 316, 2104–2114.
Lau, J., Ioannidis, J. P., Terrin, N., Schmid, C. H., and Olkin, I. (2006). Evidence based
medicine: The case of the misleading funnel plot. BMJ: British Medical Journal pages
597–600.
Liang, K.-Y. and Self, S. G. (1996). On the asymptotic behaviour of the pseudolikelihood
ratio test statistic. Journal of the Royal Statistical Society. Series B. Methodological 58,
785–796.
Light, R. and Pillemer, D. B. (1984). Summing up. Harvard University Press.
Lindsay, B. G. (1988). Composite likelihood methods. Contemporary Mathematics 80, 221–
Testing small study effects in multivariate meta-analysis 23
39.
Macaskill, P., Walter, S. D., and Irwig, L. (2001). A comparison of methods to detect
publication bias in meta-analysis. Statistics in medicine 20, 641–654.
Molenberghs, G. and Verbeke, G. (2005). Models for discrete longitudinal data. Springer.
Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R., and Rushton, L. (2006). Comparison
of two methods to detect publication bias in meta-analysis. Journal of the American
Medical Association 295, 676–680.
Riley, R., Thompson, J., and Abrams, K. (2008). An alternative model for bivariate random-
effects meta-analysis when the within-study correlations are unknown. Biostatistics 9,
172–186.
Rothstein, H. R., Sutton, A. J., and Borenstein, M. (2006). Publication bias in meta-analysis:
Prevention, assessment and adjustments. John Wiley & Sons.
Ru¨cker, G., Schwarzer, G., and Carpenter, J. (2008). Arcsine test for publication bias in
meta-analyses with binary outcomes. Statistics in medicine 27, 746–763.
Schwarzer, G., Carpenter, J. R., and Ru¨cker, G. (2015). Small-study effects in meta-analysis.
In Meta-Analysis with R, pages 107–141. Springer.
Song, F., Eastwood, A. J., Gilbody, S., Duley, L., and Sutton, A. J. (2000). Publication and
related biases. Health technology assessment (Winchester, England) 4, 1.
Sterne, J. A. and Egger, M. (2001). Funnel plots for detecting bias in meta-analysis:
guidelines on choice of axis. Journal of clinical epidemiology 54, 1046–1055.
Sutton, A. J., Duval, S., Tweedie, R., Abrams, K. R., Jones, D. R., et al. (2000). Empirical
assessment of effect of publication bias on meta-analyses. British Medical Journal 320,
1574–1577.
Trikalinos, T. A., Hoaglin, D. C., and Schmid, C. H. (2014). An empirical comparison
of univariate and multivariate meta-analyses for categorical outcomes. Statistics in
24 Biometrics, 0000
medicine 33, 1441–1459.
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., and Rosenthal, R. (2008).
Selective publication of antidepressant trials and its influence on apparent efficacy. New
England Journal of Medicine 358, 252–260.
Turner, R. M., Bird, S. M., and Higgins, J. P. (2013). The impact of study size on meta-
analyses: examination of underpowered studies in cochrane reviews. PLoS One 8, e59202.
Testing small study effects in multivariate meta-analysis 25
All−Cause Mortality
St
an
da
rd
 E
rro
r
1.
78
4
1.
33
8
0.
89
2
0.
44
6
0
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l
l l
l
l
l
−4 −2 0 2 4
Mental Quality of Life
St
an
da
rd
 E
rro
r
0.
44
7
0.
33
5
0.
22
4
0.
11
2
0
l
l
ll
l
l
ll
l
l
l
ll
l
−1 −0.5 0 0.5 1
Case study 1
Overall Survival
St
an
da
rd
 E
rro
r
1.
46
1.
09
5
0.
73
0.
36
5
0
l
l
l
l
l
l
l
l
l
l
−2 −1 0 1 2 3 4
Disease−Free Survival
St
an
da
rd
 E
rro
r
1.
73
3
1.
3
0.
86
7
0.
43
3
0
l
ll
l
l
l
l
l
l
l
l
l
l
l
l
l l
l
l
l
l l
l
l
l
l
l
l
l
ll
l
l
l
l
l
l l
l
l
l
l
l
ll
l
l
l
l
l
−2 0 2 4 6
Case study 2
Figure 1. Funnel plots for Case study 1 in Section 4.1 (upper panels) and Case study 2
in Section 4.2 (lower panels).
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Figure 3. Power plots of the proposed MSSET test, Egger’s regression test on one outcome
(Egger1), and Egger’s regression test on two outcomes with Bonferroni correction (Egger) at
the 10% nominal level for sample sizes varying from 25 to 100 and between-study variances
varying from 0.25 to 5.
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Table 1
p-Values of testing SSE using Egger’s test, Begg’s test, and the proposed score test (msset).
Test Outcome 1 Outcome 2
Case study 1 Egger 0.09 0.06
MSSET 0.03
Case study 2 Egger 0.01 0.58
MSSET 0.02
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Table 2
Type I errors (×100%), at the 10% nominal level, of Egger’s test, Begg’s test, and the proposed MSSET test. The
univariate tests are conducted on the first outcome only, denoted as “test1”, and the Bonferroni correction is used to
combine the test results, denoted as “test”. The number of studies n is 10, 25, 50, 75, and 100, and the
between-study heterogeneity τ2 is 0.1, 0.9, and 1.9.
n τ 2 MSSET Egger1 Egger Begg1 Begg
10 0.1 12.9 14.7 15.8 2.4 2.1
0.9 12.7 13.2 14.6 2.6 2.0
1.9 11.9 13.1 15.0 2.3 1.6
25 0.1 11.3 11.9 13.0 17.8 22.4
0.9 11.1 11.4 12.2 24.1 32.7
1.9 10.9 11.3 12.0 24.6 33.7
50 0.1 10.4 10.7 10.9 38.1 51.8
0.9 10.5 10.8 10.6 44.7 61.7
1.9 10.4 10.9 10.6 45.5 62.8
75 0.1 10.0 9.8 9.8 48.2 65.5
0.9 10.3 10.2 9.8 55.9 73.8
1.9 10.1 10.5 10.2 56.6 74.8
100 0.1 9.9 9.9 9.6 55.4 72.1
0.9 9.7 9.8 9.7 62.0 79.8
1.9 9.7 10.2 9.6 63.0 80.7
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Table 3
Type I errors (×100%), at the 10% nominal level, of the proposed MSSET test using smoothed variance
(MSSETsmooth), the Egger’s test on the first outcome only using smoothed variance (Egger1,smooth), and using the
original variance (Egger1), the Egger’s test on both outcomes using Bonferroni correction and using smoothed
variance (Eggersmooth), and using the original variance (Egger). The number of studies n is 10, 25, 50, 75, and 100,
and the between-study heterogeneity τ2 is 2.5.
n MSSETsmooth Egger1,smooth Egger1 Eggersmooth Egger
10 13.7 13.6 13.9 14.9 15.0
25 11.2 12.4 12.6 12.9 12.9
50 10.2 11.1 11.8 11.3 11.6
75 10.6 10.0 11.8 10.3 11.0
100 10.3 8.7 10.5 10.0 11.7
Testing small study effects in multivariate meta-analysis 31
Table 4
Contingency table of the proposed MSSET test vs. Egger’s regression based on outcome 1 (Egger1) only and outcome
2 only (Egger2), and Egger test using Bonferroni correction to combine the results from Egger’s test of bivariate
outcomes (EggerBonferroni) (i.e., S=1 if p-value < 0.1; S=0 if p-value > 0.1).
Egger1 Egger2 EggerBonferroni
MSSET S=0 S=1 S=0 S=1 S=0 S=1
S=0 31 3 31 3 31 3
S=1 6 1 6 1 4 3
